The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4830810 5691899 F 4830810-8 20010101 20041202 20051117 EXP US-MERCK-0412USA00647 MERCK HUMAN HEALTH DIVISION 51 YR F Y 98 KG 20051118 MD UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4830810 1006635453 PS VIOXX 1 ORAL 21042
4830810 1006635454 SS VIOXX 1 ORAL 021042
4830810 1006635455 SS VIOXX 1 ORAL 021042
4830810 1006635456 SS VIOXX 1 ORAL 021042
4830810 1006635457 C BAYER ENTERIC ASPIRIN 2 UNKNOWN
4830810 1006635458 C TENORMIN 1 UNKNOWN

Indications of drugs used

Event ID DRUG SEQ INDI PT
4830810 1006635453 ARTHRITIS
4830810 1006635455 ARTHRALGIA

Outcome of event

Event ID OUTC COD
4830810 HO
4830810 OT

Reactions reported

Event ID PT
4830810 ANHEDONIA
4830810 ANXIETY
4830810 ARRHYTHMIA
4830810 ARTHRITIS
4830810 ARTHROPATHY
4830810 BACK PAIN
4830810 BREAST PAIN
4830810 BURNING SENSATION
4830810 CEREBROVASCULAR ACCIDENT
4830810 CHEST PAIN
4830810 CONFUSIONAL STATE
4830810 CRYING
4830810 DEPRESSION
4830810 DIABETES MELLITUS
4830810 DYSPNOEA
4830810 EMOTIONAL DISTRESS
4830810 FACIAL PARESIS
4830810 FATIGUE
4830810 FEELING ABNORMAL
4830810 FEELING HOT
4830810 GASTRITIS
4830810 GASTROOESOPHAGEAL REFLUX DISEASE
4830810 HERPES ZOSTER
4830810 HIP DYSPLASIA
4830810 HOT FLUSH
4830810 HYPERPARATHYROIDISM
4830810 HYPERTENSION
4830810 HYPOAESTHESIA
4830810 INCREASED APPETITE
4830810 MASS
4830810 MENSTRUATION IRREGULAR
4830810 METABOLIC SYNDROME
4830810 MUSCLE SPASMS
4830810 MUSCULAR WEAKNESS
4830810 MYOCLONUS
4830810 NECK PAIN
4830810 NERVE COMPRESSION
4830810 OBESITY
4830810 OSTEOARTHRITIS
4830810 PAIN IN EXTREMITY
4830810 PARATHYROID TUMOUR BENIGN
4830810 SINUSITIS
4830810 SNORING
4830810 TRANSIENT ISCHAEMIC ATTACK
4830810 VARICOSE VEIN
4830810 VERTEBROBASILAR INSUFFICIENCY
4830810 WEIGHT INCREASED

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4830810 1006635453 20000101 20040930 5 YR
4830810 1006635454 20040101
4830810 1006635455 20000101 20040930 5 YR
4830810 1006635456 20040101